A trial assessing an experimental AstraZeneca cancer drug was placed on clinical hold due to safety concerns. The trial pause comes two years after Amgen was also forced to pause a study of a drug within the same class.
If you are not happy with the results below please do another search
50 search results for:
F-star Therapeutics announced a new partnership with Janssen Biotech on Oct. 20, only one month after presenting an optimistic trial-in-progress update to the public on the clinical-stage biopharma company’s tetravalent dual T-cell agonist FS120 at the European Society for Medical Oncology 2021 Conference.
British health authorities, as well as global experts, are closely watching a subtype of the Delta variant that appears to be rising in the UK.
A booster dose of the Covid-19 vaccine developed by Pfizer Inc. and German partner BioNTech SE restored efficacy to 95.6 percent against the virus, including the Delta variant, data released by the companies from a large study showed on Oct. 21.
Japan’s Shionogi & Co. Ltd. said on Oct. 20 the company started a Phase II/III clinical trial for the drugmaker’s Covid-19 vaccine candidate.
Novartis agreed to expand the company’s fill-and-finish support for the Pfizer/BioNTech Covid-19 vaccine by using manufacturing facilities in Ljubljana, Slovenia, to fill at least 24 million doses in 2022, the Swiss drugmaker said on Oct. 21.
The U.S. Food and Drug Administration on Oct. 20 authorized booster doses of the Covid-19 vaccines from Moderna Inc. and Johnson & Johnson, and the regulatory agency said Americans can choose a different shot from their original inoculation as a booster.
SOLVE(D), IPG Health’s data, analytics and media company, announced the addition of five industry leaders to the agency, boosting the unit’s leadership bench strength.
Surgeons from NYU Langone Health hit a major milestone in transplantation science after successfully attaching a pig’s kidney to a human patient and watching it work for several hours.
The Biden administration on Oct. 20 outlined a plan to vaccinate millions of U.S. children ages 5 to 11 as soon as the Covid-19 shot is authorized for them, readying doses and preparing locations ahead of the busy holiday season.